ARCHIVES

Free Standing Cancer Center Firms Expanding Markets

This article is from The Cancer Letter archive.

Vol. 12 No. 08 | February 21, 1986

Download PDF Visit The Full Archive

Related Articles

FDA Approves Gleevec In 73 Days, A Speed Record.

May 18, 2001

DCT Advisors Okay Two New RFA Concepts In Clinical Research, Biodiversity Groups

November 8, 1991

Advisors Clear Herceptin; Find Tamoxifen Indicated For “Short Term Risk Reduction”

September 11, 1998

NCI Clarifies IRPG Application Receipt, Funding Policies

September 3, 1993

Soybean Studies, Computing Support Recompetition Ok’d

November 9, 1990

DCT Board Approves Reissuing Surgical Oncology RFA For Planning, Okays New Recompleting Projects

June 17, 1983